Exsera BioLabs

Exsera BioLabs is a CAP/CLIA-certified niche laboratory specializing in autoimmune and complement testing, all conducted in compliance with FDA GxPs. We provide esoteric testing to support diagnostics and biomarker translation, with a strong focus on both autoimmune diseases and complement-related conditions. Our collaborations with researchers, biotech, and pharmaceutical companies help advance scientific discoveries and drug development, particularly in these areas. The leadership team at Exsera BioLabs, led by Dr. Frazer-Abel and Dr. Nandakumar, brings over three decades of combined experience in autoimmune and complement testing. Based at the University of Colorado’s Anschutz Medical Campus and surrounded by hospital affiliate sites, our team benefits from an academic environment that enhances our ability to provide expert insights and cutting-edge diagnostics. Supported by a dedicated Quality Assurance Unit, we ensure that all testing meets the highest industry standards. As well as having a dedicated data management team, who ensure that data is reconciled and delivered in a timely manner. Exsera offers over three dozen validated tests for autoimmune and complement-related conditions, including rheumatoid arthritis, systemic connective tissue diseases, antiphospholipid syndrome, vasculitis, autoimmune hepatitis, and diseases of complement deficiencies and dysregulation. We continuously refine our tests to meet the evolving needs of clinicians, particularly those working with emerging biomarkers and complement therapeutics. As a recognized leader in autoimmune and complement testing, Exsera is committed to delivering high-quality, timely results. In addition to human testing, we offer services for non-human primates, canines, and mice, providing tailored solutions to meet the unique challenges of our clients and advance patient care.